These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6300737)

  • 1. Motion sickness: a modulatory role for the central cholinergic nervous system.
    Kohl RL; Homick JL
    Neurosci Biobehav Rev; 1983; 7(1):73-85. PubMed ID: 6300737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motion sickness is linked to nystagmus-related trigeminal brain stem input: a new hypothesis.
    Gupta VK
    Med Hypotheses; 2005; 64(6):1177-81. PubMed ID: 15823712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motion sickness may be caused by a neurohumoral action of acetylcholine.
    Eisenman LM
    Med Hypotheses; 2009 Nov; 73(5):790-3. PubMed ID: 19497682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reduction of vestibulo-visual integration during transdermally administered scopolamine and dimenhydrinate. A presentation of gain control theory in motion sickness.
    Pyykkö I; Schalén L; Jäntti V; Magnusson M
    Acta Otolaryngol Suppl; 1984; 406():167-73. PubMed ID: 6332454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiopathogenesis of motion sickness].
    Iuganov EM; Solodovnik FA
    Izv Akad Nauk SSSR Biol; 1976; (4):485-94. PubMed ID: 799642
    [No Abstract]   [Full Text] [Related]  

  • 6. Vestibular influences on the histaminergic and cholinergic systems in the rat brain.
    Horii A; Takeda N; Yamatodani A; Kubo AT
    Ann N Y Acad Sci; 1996 Jun; 781():633-4. PubMed ID: 8694460
    [No Abstract]   [Full Text] [Related]  

  • 7. [The role of cholinergic mechanisms in altering the functional activity of the rabbit brain during motion sickness].
    Maksimuk VF; Skoromnyĭ NA
    Fiziol Zh SSSR Im I M Sechenova; 1988 Aug; 74(8):1109-19. PubMed ID: 3197853
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-cholinergics mecamylamine and scopolamine alleviate motion sickness-induced gastrointestinal symptoms through both peripheral and central actions.
    Qi R; Su Y; Pan L; Mao Y; Liang L; Dai Z; Wang J; Cai Y
    Neuropharmacology; 2019 Mar; 146():252-263. PubMed ID: 30543811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of vestibular trophic function in the mechanism of the vestibulo-autonomic manifestations of motion sickness].
    Arlashchenko NI
    Kosm Biol Aviakosm Med; 1981; 15(3):89-91. PubMed ID: 6974806
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic influence on vestibular stimulation-induced locus coeruleus inhibition in rats.
    Nishiike S; Takeda N; Uno A; Kubo T; Yamatodani A; Nakamura S
    Acta Otolaryngol; 2000 Mar; 120(3):404-9. PubMed ID: 10894417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurochemical mechanisms of the development of motion sickness].
    Iasnetsov VV; Shashkov VS
    Vestn Ross Akad Med Nauk; 1992; (7):16-21. PubMed ID: 1281702
    [No Abstract]   [Full Text] [Related]  

  • 12. The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.
    Zhang LL; Liu HQ; Yu XH; Zhang Y; Tian JS; Song XR; Han B; Liu AJ
    CNS Neurosci Ther; 2016 Aug; 22(8):715-22. PubMed ID: 27160425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cholinergic mechanisms in alterations of rabbit brain functional activity during sea-sickness.
    Maksimuk VF; Skoromnyi NA
    Neurosci Behav Physiol; 1990; 20(1):36-45. PubMed ID: 2352618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of calcitonin gene-related peptide in efferent vestibular system and vestibular nucleus in rats with motion sickness.
    Xiaocheng W; Zhaohui S; Junhui X; Lei Z; Lining F; Zuoming Z
    PLoS One; 2012; 7(10):e47308. PubMed ID: 23056625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat.
    Xu LH; Tang GR; Yang JJ; Liu HX; Li JC; Jiang ZL
    Mol Brain; 2015 Dec; 8():86. PubMed ID: 26651338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Labyrinthine and extralabyrinthine mechanisms of the development of motion sickness in weightlessness].
    Egorov AD; Iuganov EM
    Kosm Biol Aviakosm Med; 1985; 19(2):4-11. PubMed ID: 3887028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical mechanisms of motion sickness.
    Takeda N; Morita M; Hasegawa S; Kubo T; Matsunaga T
    Am J Otolaryngol; 1989; 10(5):351-9. PubMed ID: 2573285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of the anti-motion sickness effect of 3-hydroxypyridine derivatives].
    Iasnetsov VV; Pravdivtsev VA; Shashkov AV; Smirnov LD; Iasnetsov VV; Kozlov SB; Ivanov IuV
    Aviakosm Ekolog Med; 2005; 39(4):45-50. PubMed ID: 16353627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensory conflict theory of space motion sickness: an anatomical location for the neuroconflict.
    Kohl RL
    Aviat Space Environ Med; 1983 May; 54(5):464-5. PubMed ID: 6870740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of efferent cholinergic terminals and alpha-bungarotoxin binding to putative nicotinic acetylcholine receptors in the human vestibular end-organs.
    Ishiyama A; Lopez I; Wackym PA
    Laryngoscope; 1995 Nov; 105(11):1167-72. PubMed ID: 7475869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.